维普期刊资源整合服务平台（V6.5）

179篇 您的检索式：期刊名="Future Med Chem"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Current limita- tions and future opportunities for epigenetic therapies 显示文摘	Cherblanc F Chapman- Rothe N Brown R	2012	Future Med Chem2012，4，4：	1
2	Eukaryotic initiation factor 4F: a vulnerability of tumor cells 显示文摘	Lee T Pelletier J	2012	Future Med Chem2012，4，：	1
3	New approaches to targe- ting the actin cytoskeleton for chemotherapy 显示文摘	Bonello T T Stehn J R Gunning P W	2009	Future Med Chem2009，1，7：	1
4	The nitroimidazooxazines(PA-824 and analogs):structure-activity relationship and mechanistic studies显示文摘	Denny WA Palmer BD	2010	Future Med Chem2010，2，8：	1
5	New agents to treat lung infection in cystic fibrosis:a big enough leap显示文摘	Hurley M Smyth A	2013	Future Med Chem2013，5，2：	1
6	The emerging role Of 'CXC chemokines and their receptors in cancer显示文摘	Vinader V Afarinkia K	2012	Future Med Chem2012，4，7：	1
7	Paradigm shift in discove- ring next-generation anti-infective agents: targeting quorum sensing, c-di-GMP signaling and biofilm formation in bacteria with small molecules显示文摘	Sintim HO Smith JA Wang J	2010	Future Med Chem2010，2，6：	1
8	SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treat- ment option for metabolic disorders显示文摘	Mercader J Iffiu-Sohesz Z Brenachot X	2010	Future Med Chem2010，2，12：	1
9	Dynamical insights of Mnk2 kinase activation by phosphorylation to facilitate inhibitor discovery显示文摘	KUMARASIRI M TEO T WANG S	2015	Future Med Chem2015，7，2：	1
10	An update on dual Src/Abl inhibitors 显示文摘	Musumei F Schenone S Brullo C	2012	Future Med Chem2012，4，6：	1
11	Celecoxib and Bcl-2: emerging possibilities for antieancer drug design显示文摘	WINFIELD LL PAYTON-STEWART F	2012	Future Med Chem2012，4，3：	1
12	New modalities in conformationally constrained peptides for potency, selectivity and cell permeation 显示文摘	Dharanipraqada R	2013	Future Med Chem2013，5，7：	1
13	Nuclear receptorsas pharmaceutical targets:rise of FXR and rebirth ofPPAR显示文摘	Merk D Schubert-Zsilavecz M	2012	Future Med Chem2012，4，5：	1
14	Farnesoid X receptor:From medicinal chemistry to clinical applica- tions显示文摘	Fiorucei S Mencarelli A Distrutti E	2012	Future Med Chem2012，4，7：	1
15	Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics 显示文摘	Sayaka M Linhardt RJ	2012	Future Med Chem2012，4，6：	1
16	Discovery of fingolimod,the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis显示文摘	Chiba K Adachi K	2012	Future Med Chem2012，4，6：	1
17	Discov- cry of OS1-906:a selective and orally efficacious dual inhibitor of the IGF1 receptor and insulin receptor显示文摘	Mulvihill M J Cooke A Rosenfeld-Franklin M	2009	Future Med Chem2009，1，6：	1
18	New agents to treat lung infection in cystic fibrosis: a big enough leap显示文摘	Hurley M Smyth A	2013	Future Med Chem2013，5，2：	1
19	Small - molecule inhibitors of the PI3 K signaling network 显示文摘	McNamara CR Degterev A	2011	Future Med Chem2011，3，5：	1
20	Manufacturing peptides as active pharmaceutical ingredients 显示文摘	Zompra AA Galanis AS Werbitzky O	2009	Future Med Chem2009，1，：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示